Lineage Cell Therapeutics (LCTX) has a market capitalization of $162.4M, based on 228.31M shares at a price of $0.71 (down 1.9% today).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
February 2025 | $0.72 | 14,593,395 | 228,311,017 | $165,502,656.22 |
January 2025 | $0.60 | 48,198,712 | 228,311,017 | $137,146,427.91 |
December 2024 | $0.50 | 50,165,166 | 188,835,000 | $94,889,587.50 |
November 2024 | $0.57 | 58,092,085 | 188,835,000 | $107,994,736.50 |
October 2024 | $0.83 | 10,100,032 | 188,835,000 | $156,978,535.50 |
September 2024 | $0.91 | 7,358,407 | 188,835,000 | $170,952,325.50 |
August 2024 | $0.88 | 12,354,155 | 188,835,000 | $166,911,256.50 |
July 2024 | $1.03 | 13,110,495 | 188,835,000 | $194,500,050.00 |
June 2024 | $1.00 | 18,253,103 | 188,813,000 | $188,303,204.90 |
May 2024 | $1.00 | 29,113,550 | 188,813,000 | $188,813,000.00 |
April 2024 | $1.09 | 20,206,933 | 188,813,000 | $205,806,170.00 |
March 2024 | $1.48 | 21,860,426 | 182,909,000 | $270,705,320.00 |
February 2024 | $1.04 | 17,174,106 | 182,909,000 | $190,225,360.00 |
January 2024 | $0.93 | 17,112,290 | 182,909,000 | $170,123,660.90 |
December 2023 | $1.09 | 14,556,686 | 172,663,000 | $188,202,670.00 |
November 2023 | $0.98 | 9,669,020 | 172,663,000 | $169,555,066.00 |
October 2023 | $1.14 | 9,981,258 | 172,663,000 | $196,835,820.00 |
September 2023 | $1.18 | 9,410,055 | 174,868,000 | $206,344,240.00 |
August 2023 | $1.32 | 8,481,197 | 174,868,000 | $230,825,760.00 |
July 2023 | $1.53 | 10,276,583 | 174,868,000 | $267,548,040.00 |
June 2023 | $1.41 | 31,618,381 | 170,592,000 | $240,534,720.00 |
May 2023 | $1.26 | 6,928,398 | 170,592,000 | $214,945,920.00 |
April 2023 | $1.36 | 7,032,233 | 170,592,000 | $232,005,120.00 |
March 2023 | $1.50 | 7,716,250 | 170,127,000 | $255,190,500.00 |
February 2023 | $1.35 | 6,798,643 | 170,127,000 | $229,671,450.00 |
